Xenon Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

2.2yrs

Average management tenure


CEO

Ian Mortimer (46 yo)

1.33yrs

Tenure

US$3,894,997

Compensation

Mr. Ian C. Mortimer, M.B.A, C.P.A, C.M.A., has been the Chief Executive Officer and Director at Xenon Pharmaceuticals Inc. since June 03, 2021. He has been Director at Perimeter Medical Imaging AI, Inc. si...


CEO Compensation Analysis

Ian Mortimer's Compensation vs Xenon Pharmaceuticals Earnings
How has Ian Mortimer's remuneration changed compared to Xenon Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-US$92m

Mar 31 2022n/an/a

-US$83m

Dec 31 2021US$4mUS$524k

-US$79m

Sep 30 2021n/an/a

-US$66m

Jun 30 2021n/an/a

-US$59m

Mar 31 2021n/an/a

-US$37m

Dec 31 2020US$2mUS$462k

-US$29m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$38m

Dec 31 2019US$2mUS$421k

-US$42m

Sep 30 2019n/an/a

-US$39m

Jun 30 2019n/an/a

-US$44m

Mar 31 2019n/an/a

-US$42m

Dec 31 2018US$923kUS$342k

-US$34m

Sep 30 2018n/an/a

-US$34m

Jun 30 2018n/an/a

-US$27m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$945kUS$312k

-US$31m

Sep 30 2017n/an/a

-US$29m

Jun 30 2017n/an/a

-US$29m

Mar 31 2017n/an/a

-US$27m

Dec 31 2016US$555kUS$261k

-US$23m

Sep 30 2016n/an/a

-US$21m

Jun 30 2016n/an/a

-US$17m

Mar 31 2016n/an/a

-US$10m

Dec 31 2015US$1mUS$256k

-US$16m

Compensation vs Market: Ian's total compensation ($USD3.89M) is about average for companies of similar size in the US market ($USD5.48M).

Compensation vs Earnings: Ian's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: XENE's management team is considered experienced (2.2 years average tenure).


Board Members

Experienced Board: XENE's board of directors are considered experienced (6.8 years average tenure).